Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trialWilliam Barbour, Subodh Verma, Pankaj Puar et al.|BMC Cardiovascular Disorders|2023Cited by 2